Kur ieškoti informacijos? Pagrindiniai dokumentai

Darbo programa (WP 2018-2020)

Kvietimai teikti paraiškas (3 kvietimai; 28 temos)

Portalas: Funding & Tenders portal

EK 2019 m. info dienos pranešimai

LMT puslapis

NCP

https://www.healthncp.net/

2

SC1 Open Calls

Call - Better Health and care, economic growth and sustainable health systems -6 thematic areas -21 topics

Call - Digital transformation in Health and Care6 topics

Call - Trusted digital solutions and Cybersecurity in Health and Care1 topic

3

Tyrimų prioritetai 2018-2020 m.

Aplinkos vaidmens sveikatai ir gerovei dekodavimas

Personalizuota medicina

Infekcinės ligos ir pasaulinis sveikatos gerinimas

Skaitmeninės transformacijos

sveikatoje ir priežiūroje

Inovatyvios sveikatos ir priežiūros sistemos –

priežiūros integracija

Inovatyvi sveikatosir priežiūros

pramonė

SC1

Sveikata, demografiniai

pokyčiai ir gerovė

Patikimi skaitmeniniai sprendimai ir

kibernetinis saugumas sveikatai ir priežiūrai4

Call - Better Health and care, economic growth and sustainable health systems

Aim• Toward healthy ageing • Industries orientated research - to translate new knowledge into innovative

applications, inclusion of innovators in the projects is encouraged

Priorities• Personalised medicine (6 topics)• Innovative health and care industry (3 topics)• Infectious diseases and improving global health (7 topics)• Innovative health and care systems - Integration of care (2 topics)• Decoding the role of the environment, including climate change, for health and

well-being (1 topic)• Supporting the digital transformation in health and care (2 topic)

5

Personalised medicineAim• generate and translate knowledge on disease aetiology and technological innovation;

application in chronic, rare and communicable diseases• develop an understanding of the economic impact and the potential of personalised

medicine

Topics Opening: 04 Jul 2019• SC1-BHC-06-2020: Digital diagnostics – developing tools for supporting clinical decisions

by integrating various diagnostic data, RIA USA eligible• SC1-HCO-03-2020: Bridging the divide in health research and innovation – boosting

return on investment (Widening flagged topic), CSA USA eligible• SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for

Personalised Medicine, CSA• SC1-HCO-14-2020: ERA-NET: Sustained collaboration of national and regional

programmes in cancer research, CSA• SC1-HCO-16-2020: ERA-NET: Sustained collaboration of national and regional

programmes in research on brain-related diseases and disorders of the nervous system, CSA

• SC1-HCO-17-2020: Coordinating and supporting research on the human microbiome in Europe and beyond, CSA 6

Innovative health and care industry

Aimturn innovative knowledge and technologies into practice; for most innovative stakeholders (SMEs)

Topics Opening: 04 Jul 2019 USA eligible• SC1-BHC-11-2020: Advancing the safety assessment of chemicals without the

use of animal testing (animal-free approaches to toxicological profiling of chemicals safety assessment), RIA

• SC1-HCO-18-2020: Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices, CSA

• SC1-HCO-19-2020: Reliable and accessible information on cell and gene-based therapies (strategies to convey accurate and up-to-date information on cell and gene-based therapies), CSA

7

Infectious diseases and improving global healthAimimprove the risk assessment and surveillance tools, develop the innovative medical countermeasures addressing in particular antimicrobial resistance, emerging and re-emerging infectious diseases, poverty-related and neglected diseases; address low-vaccine uptake; maternal and new-born health

Topics Opening: 4 Jul 2019• SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions• SC1-BHC-20B-2020: Public procurement of innovative solutions (PPI) for diagnostics for infectious

diseases• SC1-HCO-07-2020: ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance

(JPIAMR), CSATopics Opening: 26 Jul 2019 USA eligible• SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis

of cancer (in Low and Middle-Income Countries and/or in vulnerable populations High- Income Countries), RIA

• SC1-BHC-33-2020: Addressing low vaccine uptake (develop strategies to increase vaccination rates; proposals should include partners from social science and public health-related disciplines), RIA

• SC1-BHC-34-2020: New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings (multi-disciplinary approach for clinical management and infection prevention), RIA

• SC1-BHC-35-2020: Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases (establish a pan-European clinical research network, testing and developing new diagnostic, preventive and/or therapeutic strategies and therapies), RIA8

Innovative health and care systems - Integration of care

AimFunding opportunities for clinical trialsaccessible and sustainable health interventions and integrated care systems relevant in the context of personalised medicine, management of chronic diseases and health promotion; development of health technology assessment methods, the management of elderly multimorbid patients (SSH flagged priority)

Topics Opening: 04 Jul 2019 USA eligible• SC1-BHC-24-2020: Healthcare interventions for the management of the elderly multi-

morbid patient (The patient-centered approach should be holistic, inclusive, cross-sectoral and interdisciplinary), RIA

• SC1-BHC-37-2020: Towards the new generation of clinical trials – trials methodology research (scientific evidence to ensure optimal health interventions; All literature analyses to define the current state of the art in the clinical trial methodology research must be completed at the time of submission of the proposal; research related to clinical studies exclusively on medical devices is not in the scope of this topic), lump sum pilot RIA-LS 9

Decoding the role of the environment, including climate change, for health and well-being

AimFive items: 1) identification of endocrine disrupting chemicals; 2) assessment of the totality of the life-long environmental influences; 3) the impact of micro- and nano-plastics; 4) a European environment and health research agenda for the future; 5) IA for urban health and wellbeing

multi-disciplinary approach: environmental technology and sciences, ocean sciences, bio-medical sciences, materials science and nanotechnologies, exposure science, analytical chemistry, biotechnology, food sciences, business model and product design, systems thinking and behavioural sciences

Topic Opening: 04 Jul 2019 USA eligible• SC1-BHC-36-2020: Micro- and nano-plastics in our environment:

Understanding exposures and impacts on human health (science-based risk assessment and management), RIA 10

Supporting the Digital transformation in Health and Care

Aimdeveloping a Health Research and Innovation Cloud; fostering more digitised and community-based care models

Topics Opening: 04 Jul 2019 USA eligible• SC1-DTH-12-2020: Use of Real-World Data to advance research on the

management of complex chronic conditions (The use of new technologies for data analytics and interpretation such as artificial intelligence and computer modelling are encouraged; Research that focuses on self-management only is not in the scope of this topic. Research on rare and/or infectious diseases are excluded from the scope of this topic), RIA

• SC1-HCC-10-2020: Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research (design an implementation roadmap /strategic agenda for a one-stop shop, a HRIC FAIR data portal respecting legal and ethics requirements), CSA

11

Call - Digital transformation in Health and CareAim

more digitised, person-centred and community-based care models

Topics Opening: 19 Nov 2019

• SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention based on Artificial Intelligenceand Big Data technologies (Personalised early risk prediction models; innovative ICT based solutions for adequate personalised preventive measures (e.g. behavioural change, diet, interventions, medication, primary prevention) from advanced predictive models), RIA

• SC1-DTH-04-2020: International cooperation in smart living environments for ageing people (provide innovative user-friendly user interfaces such as voice-based interaction, personalised advice, guidance and follow-up for key age and health related issues in daily life; trans-disciplinary research, involving behavioural, sociological, psychological, medical and other relevant disciplines, including gender and cultural aspects); RIA that should address one of the following international collaboration possibilities: 1. Cooperation with Japan; 2. Collaboration with Canada

• SC1-DTH-06-2020: Accelerating the uptake of computer simulations for testing medicines and medical devices(evaluation of medicines and/or medical devices to become closer to the market; multidisciplinary effort (e.g. within the fields of computational modelling, chemo/bio-informatics, systems biology, pharmacology, -omics (genomics, epigenetics, metabolomics), tissue mechanics, biology, pharmaceutics, medicine, physiology, toxicology, social science aspects such as gender), RIA

• SC1-HCC-09-2019-2020: Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes, CSA

• SC1-DTH-14-2020: Pre-commercial Procurement for Digital Health and Care Solutions, PCP

• SC1-HCC-08-2020: Scaling up innovation for active and healthy ageing, CSA12

Call - Trusted digital solutions and Cybersecurity in Health and Care

AimICT-based solutions in early risk detection and interventions with big data

approaches

Topics• DT-TDS-04-2020: AI for Genomics and Personalised Medicine

(demonstrate a potential to build a large-scale distributed repository of relevant genomic data and other -omics and medical data that will enable to advance validation of the new clinically impactful insights supported trough AI solutions), RIA, Opening: 19 Nov 2019

• DT-TDS-05-2020: Artificial Intelligence (AI) for Health Imaging (testing and developing AI tools and analytics focused on the prevention, prediction and treatment of the most common forms of cancer), RIA, Opening: 09 Jul 2019 13

Projektinė

veikla

Finansavimo

schemos kodas Minimalios dalyvavimo sąlygos

Maksimalus

finansavimo

intensyvumas

Trukmė,

mėn. Tikslas

Moksliniai

tyrimai ir

inovacijos

RIA 3 nepriklausomi juridiniai asmenys,įsteigti ES valstybėse narėse arasocijuotose šalyse

100 %

(vid. 2-5 mln.)36-48

Kurti naujas žinias ar naujas technologijas.

Inovacijų

veikla IA

3 nepriklausomi juridiniai asmenys,įsteigti ES valstybėse narėse arasocijuotose šalyse

100 % – pelnonesiekiančiomsorganizacijoms;70 % – kitiemsjuridiniamsasmenims(vid. 2-5 mln.)

30-36

Kurti naujus produktus, procesus ar paslaugas arba iš esmės tobulinti jau sukurtus ar įdiegtus.

Koordinavimas

ir parama CSA

1 juridinis asmuo, įsteigtas ESvalstybėje narėje ar asocijuotoješalyje

100 %

(vid. 0,5-2 mln.)12-30

Mokslinės veiklos (standartizavimas, viešinimas) bei mokslo politikos (politiniai dialogai, studijos) strateginis koordinavimas

Ikiprekybiniai ir

Inovatyvių

sprendimų

viešieji pirkimai

PCP ir PPI

3 nepriklausomi juridiniai asmenys,įsteigti ES valstybėse narėse arasocijuotose šalyse, ne mažiau kaip 2iš jų viešųjų pirkimų organizacijos

Iki 90 % PCP, iki 35% PPI

Pasirengimas viešiesiems pirkimams ir jų vykdymas

Finansavimo schemos(pagal HORIZON 2020 – WORK PROGRAMME 2018-2020

General Annexes)

14